The gut-brain-axis as a target to treat stress-induced obesity

Frontiers in Endocrinology

Volumn 5, Issue JUL, 2014, Pages

  Lee, Chooi Yeng ^a   Abizaid, Alfonso ^b  

^a MONASH UNIVERSITY MALAYSIA   (Malaysia)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

Brain; Gut; Gut peptides; Obesity; Stress

Indexed keywords

AGOUTI RELATED PROTEIN; APPETITE STIMULANT; BETA 2 ADRENERGIC RECEPTOR; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DOPAMINE; GASTROINTESTINAL HORMONE; GASTROINTESTINAL POLYPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LIPID; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE Y; OXYNTOMODULIN; PEPTIDE YY; UROCORTIN I;

ADIPOSE TISSUE; ANATOMICAL CONCEPTS; ANGIOGENESIS; APPETITE; BIOACCUMULATION; CALORIC INTAKE; CELL ENLARGEMENT; CELL PROLIFERATION; CELLULAR STRESS RESPONSE; ENERGY BALANCE; ENERGY EXPENDITURE; ENTEROENDOCRINE CELL; FOOD INTAKE; GASTROINTESTINAL DISEASE; GLUCOSE HOMEOSTASIS; GUT BRAIN AXIS; HUMAN; IRRITABLE COLON; LIVER FUNCTION; NERVE POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PANCREAS ISLET BETA CELL; SIGNAL TRANSDUCTION; STOMACH PARIETAL CELL; STOMACH ULCER; STRESS; VAGOTOMY;

EID: 84905402180     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00117     Document Type: Note

References (68)

1. Abizaid A, Gao Q, Horvath TL. Thoughts for food: brain mechanisms and peripheral energy balance. Neuron (2006) 51:691-702. doi:10.1016/j.neuron.2006.08.025
2. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol (2008) 85:1-74. doi:10.1016/j.pneurobio.2008.01.004
3. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev (2007) 87:873-904. doi:10.1152/physrev.00041.2006
4. Black PH. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II. Med Hypotheses (2006) 67:879-91. doi:10.1016/j.mehy.2006.04.008
5. Coccurello R, D'Amato FR, Moles A. Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Neurosci Biobehav Rev (2009) 33:537-50. doi:10.1016/j.neubiorev.2008.05.018
6. Abizaid A, Horvath TL. Brain circuits regulating energy homeostasis. Regul Pept (2008) 149:3-10. doi:10.1016/j.regpep.2007.10.006
7. Sclafani A, Ackroff K. Role of gut nutrient sensing in stimulating appetite and conditioning food preferences. Am J Physiol Regul Integr Comp Physiol (2012) 302:R1119-33. doi:10.1152/ajpregu.00038.2012
8. Rasmussen BA, Breen DM, Lam TK. Lipid sensing in the gut, brain and liver. Trends Endocrinol Metab (2012) 23:49-55. doi:10.1016/j.tem.2011.11.001
9. Schwartz GJ. Gut fat sensing in the negative feedback control of energy balance - recent advances. Physiol Behav (2011) 104:621-3. doi:10.1016/j.physbeh.2011.05.003
10. Lee CY. The effect of high fat-diet-induced pathophysiological changes in the gut on obesity: what should be the ideal treatment? Clin Transl Gastroenterol (2013) 4:e39. doi:10.1038/ctg.2013.11
11. Sam AH, Troke RC, Tan TM, Bewick GA. The role of the gut/brain axis in modulating food intake. Neuropharmacology (2012) 63:46-56. doi:10.1016/j.neuropharm.2011.10.008
12. Dham S, Banerji MA. The brain-gut axis in regulation of appetite and obesity. Pediatr Endocrinol Rev (2006) 3(Suppl 4):544-54.
13. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol (2004) 55:137-54.
14. Janssen S, Depoortere I. Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol Metab (2013) 24:92-100. doi:10.1016/j.tem.2012.11.006
15. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature (2000) 407:908-13. doi:10.1038/35038090
16. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (1999) 402:656-60. doi:10.1038/45230
17. Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun (2001) 281:1220-5. doi:10.1006/bbrc.2001.4518
18. Kristenssson E, Sundqvist M, Astin M, Kjerling M, Mattsson H, Dornonville de la Cour C, et al. Acute psychological stress raises plasma ghrelin in the rat. Regul Pept (2006) 134:114-7. doi:10.1016/j.regpep.2006.02.003
19. Ochi M, Tominaga K, Tanaka F, Tanigawa T, Shiba M, Watanabe T, et al. Effect of chronic stress on gastric emptying and plasma ghrelin levels in rats. Life Sci (2008) 82:862-8. doi:10.1016/j.lfs.2008.01.020
20. Mundinger TO, Cummings DE, Taborsky GJ Jr. Direct stimulation of ghrelin secretion by sympathetic nerves. Endocrinology (2006) 147:2893-901. doi:10.1210/en.2005-1182
21. Wang L, Stengel A, Goebel-Stengel M, Shaikh A, Yuan PQ, Tache Y. Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats. Peptides (2013) 39:164-70. doi:10.1016/j.peptides.2012.11.009
22. Tache Y, Million M, Nelson AG, Lamy C, Wang L. Role of corticotropin-releasing factor pathways in stress-related alterations of colonic motor function and viscerosensibility in female rodents. Gend Med (2005) 2:146-54. doi:10.1016/S1550-8579(05)80043-9
23. Million M, Maillot C, Saunders P, Rivier J, Vale W, Tache Y. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats. Am J Physiol Gastrointest Liver Physiol (2002) 282:G34-40. doi:10.1152/ajpgi.00283.2001
24. Brzozowski T, Konturek PC, Konturek SJ, Kwiecien S, Drozdowicz D, Bielanski W, et al. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept (2004) 120:39-51. doi:10.1016/j.regpep.2004.02.010
25. Brzozowski T, Konturek PC, Sliwowski Z, Drozdowicz D, Kwiecien S, Pawlik M, et al. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. J Physiol Pharmacol (2006) 57(Suppl 6):63-76.
26. Sibilia V, Rindi G, Pagani F, Rapetti D, Locatelli V, Torsello A, et al. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology (2003) 144:353-9. doi:10.1210/en.2002-220756
27. Patterson ZR, Khazall R, Mackay H, Anisman H, Abizaid A. Central ghrelin signaling mediates the metabolic response of C57BL/6 male mice to chronic social defeat stress. Endocrinology (2013) 154:1080-91. doi:10.1210/en.2012-1834
28. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci (2008) 11:752-3. doi:10.1038/nn.2139
29. Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol (2006) 11:45-54. doi:10.1111/j.1369-1600.2006.00002.x
30. King SJ, Isaacs AM, O'Farrell E, Abizaid A. Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area. Horm Behav (2011) 60:572-80. doi:10.1016/j.yhbeh.2011.08.006
31. Chuang JC, Perello M, Sakata I, Osborne-Lawrence S, Savitt JM, Lutter M, et al. Ghrelin mediates stress-induced food-reward behavior in mice. J Clin Invest (2011) 121:2684-92. doi:10.1172/JCI57660
32. Perello M, Sakata I, Birnbaum S, Chuang JC, Osborne-Lawrence S, Rovinsky SA, et al. Ghrelin increases the rewarding value of high-fat diet in an orexin-dependent manner. Biol Psychiatry (2010) 67:880-6. doi:10.1016/j.biopsych.2009.10.030
33. Liang C, Luo H, Liu Y, Cao J, Xia H. Plasma hormones facilitated the hypermotility of the colon in a chronic stress rat model. PLoS One (2012) 7:e31774. doi:10.1371/journal.pone.0031774
34. Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med (1987) 151:373-85. doi:10.1620/tjem.151.373
35. Jonsson BH, Hellstrom PM. Motilin- and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia. Integr Physiol Behav Sci (2000) 35:256-65. doi:10.1007/BF02688788
36. Gray TS, Morley JE. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci (1986) 38:389-401. doi:10.1016/0024-3205(86)90061-5
37. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol (1998) 402:442-59. doi:10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.3.CO;2-I
38. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med (2007) 13:803-11. doi:10.1038/nm0907-1120
39. van Dijk G, Thiele TE. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides (1999) 33:406-14. doi:10.1054/npep.1999.0053
40. O'Shea D, Gunn I, Chen X, Bloom S, Herbert J. A role for central glucagon-like peptide-1 in temperature regulation. Neuroreport (1996) 7:830-2. doi:10.1097/00001756-199602290-00035
41. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature (1996) 379:69-72. doi:10.1038/379069a0
42. Alhadeff AL, Rupprecht LE, Hayes MR. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology (2012) 153:647-58. doi:10.1210/en.2011-1443
43. Shirazi RH, Dickson SL, Skibicka KP. Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward. PLoS One (2013) 8:e61965. doi:10.1371/journal.pone.0061965
44. MacLusky NJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F, et al. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 141:752-62. doi:10.1210/en.141.2.752
45. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest (1996) 97:92-103. doi:10.1172/JCI118411
46. Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, Goke B, et al. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians (1997) 109:84-97.
47. Younce CW, Burmeister MA, Ayala JE. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a. Am J Physiol Cell Physiol (2013) 304:C508-18. doi:10.1152/ajpcell.00248.2012
48. Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, et al. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes (2013) 62:1697-708. doi:10.2337/db12-1025
49. Tsunekawa S, Yamamoto N, Tsukamoto K, Itoh Y, Kaneko Y, Kimura T, et al. Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol (2007) 193:65-74. doi:10.1677/JOE-06-0148
50. Fujita H, Morii T, Fujishima H, Sato T, Shimizu T, Hosoba M, et al. The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney Int (2014) 85:579-89. doi:10.1038/ki.2013.427
51. Nahata M, Muto S, Oridate N, Ohnishi S, Nakagawa K, Sadakane C, et al. Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease. Am J Physiol Gastrointest Liver Physiol (2012) 303:G42-53. doi:10.1152/ajpgi.00462.2011
52. Nahata M, Saegusa Y, Sadakane C, Yamada C, Nakagawa K, Okubo N, et al. Administration of exogenous acylated ghrelin or rikkunshito, an endogenous ghrelin enhancer, improves the decrease in postprandial gastric motility in an acute restraint stress mouse model. Neurogastroenterol Motil (2014) 26:821-31. doi:10.1111/nmo.12336
53. Carlini VP, Machado DG, Buteler F, Ghersi M, Ponzio MF, Martini AC, et al. Acute ghrelin administration reverses depressive-like behavior induced by bilateral olfactory bulbectomy in mice. Peptides (2012) 35:160-5. doi:10.1016/j.peptides.2012.03.031
54. Spencer SJ, Xu L, Clarke MA, Lemus M, Reichenbach A, Geenen B, et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry (2012) 72:457-65. doi:10.1016/j.biopsych.2012.03.010
55. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology (2001) 74:143-7. doi:10.1159/000054680
56. Carlini VP, Monzon ME, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun (2002) 299:739-43. doi:10.1016/S0006-291X(02)02740-7
57. Currie PJ, Khelemsky R, Rigsbee EM, Dono LM, Coiro CD, Chapman CD, et al. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res (2012) 226:96-105. doi:10.1016/j.bbr.2011.08.037
58. Hansson C, Haage D, Taube M, Egecioglu E, Salome N, Dickson SL. Central administration of ghrelin alters emotional responses in rats: behavioural, electrophysiological and molecular evidence. Neuroscience (2011) 180:201-11. doi:10.1016/j.neuroscience.2011.02.002
59. Meyer RM, Burgos-Robles A, Liu E, Correia SS, Goosens KA. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry (2013):1-11. doi:10.1038/mp.2013.135
60. Kern A, Albarran-Zeckler R, Walsh HE, Smith RG. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron (2012) 73:317-32. doi:10.1016/j.neuron.2011.10.038
61. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell (2008) 132:387-96. doi:10.1016/j.cell.2008.01.017
62. Barnett BP, Hwang Y, Taylor MS, Kirchner H, Pfluger PT, Bernard V, et al. Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor. Science (2010) 330:1689-92. doi:10.1126/science.1196154
63. Delhanty PJ, Huisman M, Baldeon-Rojas LY, van den Berge I, Grefhorst A, Abribat T, et al. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J (2013) 27:1690-700. doi:10.1096/fj.12-221143
64. Zhang W, Chai B, Li JY, Wang H, Mulholland MW. Effect of des-acyl ghrelin on adiposity and glucose metabolism. Endocrinology (2008) 149:4710-6. doi:10.1210/en.2008-0263
65. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol (2002) 159:1029-37. doi:10.1083/jcb.200207165
66. Skibicka KP, Dickson SL. Enteroendocrine hormones - central effects on behavior. Curr Opin Pharmacol (2013) 13:977-82. doi:10.1016/j.coph.2013.09.004
67. Ghosal S, Myers B, Herman JP. Role of central glucagon-like peptide-1 in stress regulation. Physiol Behav (2013) 122:201-7. doi:10.1016/j.physbeh.2013.04.003
68. McGovern SF, Hunter K, Holscher C. Effects of the glucagon-like polypeptide-1 analogue (Val8) GLP-1 on learning, progenitor cell proliferation and neurogenesis in the C57B/16 mouse brain. Brain Res (2012) 1473:204-13. doi:10.1016/j.brainres.2012.07.029